Previous studies in invertebrate and cell culture models of HD have indicated that SIRT2 inhibition alters HD-related phenotypes, particularly by modulating the expression of cholesterol biosynthesis enzymes [22], [23]. This evidence concerns the gene SIRT2 and Huntington disease.